Increased glucagon-like peptide-1 secretion and postprandial hypoglycemia in children after nissen fundoplication

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 1, 2009, Pages 39-44

  Palladino, Andrew A ^a   Sayed, Samir ^a   Levitt Katz, Lorraine E ^a,b   Gallagher, Paul R ^a   De León, Diva D ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN;

ADOLESCENT; ANAMNESIS; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYPOGLYCEMIA; INFANT; INSULIN BLOOD LEVEL; MALE; ORAL GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; PRIORITY JOURNAL; SCORING SYSTEM; STOMACH FUNDOPLICATION; SYMPTOM;

EID: 58149391357     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-1263     Document Type: Article

References (40)

1. Samuk I, Afriat R, Horne T, Bistritzer T, Barr J, Vinograd I 1996 Dumping syndrome following Nissen fundoplication, diagnosis, and treatment. J Pediatr Gastroenterol Nutr 23:235-240
2. Vu MK, Straathof JW, v d Schaar PJ, Arndt JW, Ringers J, Lamers CB, Masclee AA 1999 Motor and sensory function of the proximal stomach in reflux disease and after laparoscopic Nissen fundoplication. Am J Gastroenterol 94:1481-1489
3. Gitzelmann R, Hirsig J 1986 Infant dumping syndrome: reversal of symptoms by feeding uncooked starch. Eur J Pediatr 145:504-506
4. Ng DD, Ferry Jr RJ, Kelly A, Weinzimer SA, Stanley CA, Katz LE 2001 Acarbose treatment of postprandial hypoglycemia in children after Nissen fundoplication. J Pediatr 139:877-879
5. Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV 2005 Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 353:249-254
6. Patti ME, McMahon G, Mun EC, Bitton A, Holst JJ, Goldsmith J, Hanto DW, Callery M, Arky R, Nose V, Bonner-Weir S, Goldfine AB 2005 Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 48:2236-2240
7. Goldfine AB, Mun EC, Devine E, Bernier R, Baz-Hecht M, Jones DB, Schneider BE, Holst JJ, Patti ME 2007 Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab 92:4678-4685
8. Rodieux F, Giusti V, D'Alessio DA, Suter M, Tappy L 2008 Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity (Silver Spring) 16:298-305
9. Miholic J, Orskov C, Holst JJ, Kotzerke J, Meyer HJ 1991 Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy. Dig Dis Sci 36:1361-1370
10. Andreasen JJ, Orskov C, Holst JJ 1994 Secretion of glucagon-like peptide-1 and reactive hypoglycemia after partial gastrectomy. Digestion 55:221-228
11. Gebhard B, Holst JJ, Biegelmayer C, Miholic J 2001 Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome. Dig Dis Sci 46:1915-1923
12. De León DD, Crutchlow MF, Ham JY, Stoffers DA 2006 Role of glucagon-like peptide-1 in the pathogenesis and treatment of diabetes mellitus. Int J Biochem Cell Biol 38:845-859
13. Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeldt W 1993 Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:741-744
14. Orskov C, Holst JJ, Nielsen OV 1988 Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach. Endocrinology 123:2009-2013
15. Hvidberg A, Nielsen MT, Hilsted J, Orskov C, Holst JJ 1994 Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man. Metabolism 43:104-108
16. Larsson H, Holst JJ, Ahrén B 1997 Glucagon-like peptide-1 reduces hepatic glucose production indirectly through insulin and glucagon in humans. Acta Physiol Scand 160:413-422
17. Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ 1993 Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 38:665-673
18. Willms B, Werner J, Holst JJ, Orskov C, Creutzfeldt W, Nauck MA 1996 Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients. J Clin Endocrinol Metab 81:327-332
19. Flint A, Raben A, Astrup A, Holst JJ 1998 Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 101:515-520
20. Gutzwiller JP, Drewe J, Göke B, Schmidt H, Rohrer B, Lareida J, Beglinger C 1999 Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Am J Physiol 276:R1541-R1544
21. Vilsbøll T, Krarup T, Deacon CF, Madsbad S, Holst JJ 2001 Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 50:609-613
22. Brubaker PL, Anini Y 2003 Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2. Can J Physiol Pharmacol 81:1005-1012
23. Miholic J, Hoffmann M, Holst JJ, Lenglinger J, Mittlböck M, Bergmann H, Stacher G 2007 Gastric emptying of glucose solution and associated plasma concentrations of GLP-1, GIP, and PYY before and after fundoplication. Surg Endosc 21:309-314
24. Elliott RM, Morgan LM, Tredger JA, Deacon S, Wright J, Marks V 1993 Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute postprandial and 24-h secretion patterns. J Endocrinol 138:159-166
25. Xiao Q, Boushey RP, Drucker DJ, Brubaker PL 1999 Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans. Gastroenterology 117:99-105
26. Brynes AE, Frost GS, Edwards CM, Ghatei MA, Bloom SR 1998 Plasma glucagon-like peptide-1 (7-36) amide (GLP-1) response to liquid phase, solid phase, and meals of differing lipid composition. Nutrition 14:433-436
27. Knop FK, Vilsbøll T, Larsen S, Madsbad S, Holst JJ, Krarup T 2003 No hypoglycemia after subcutaneous administration of glucagon-like peptide-1 in lean type 2 diabetic patients and in patients with diabetes secondary to chronic pancreatitis. Diabetes Care 26:2581-2587
28. Vilsbøll T, Krarup T, Madsbad S, Holst JJ 2001 No reactive hypoglycaemia in type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose. Diabet Med 18:144-149
29. Todd JF, Wilding JP, Edwards CM, Khan FA, Ghatei MA, Bloom SR 1997 Glucagon-like peptide-1 (GLP-1): a trial of treatment in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 27:533-536
30. Toft-Nielsen MB, Madsbad S, Holst JJ 2001 Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes. J Clin Endocrinol Metab 86: 3853-3860
31. Edwards CM, Todd JF, Ghatei MA, Bloom SR 1998 Subcutaneous glucagon-like peptide-1 (7-36) amide is insulinotropic and can cause hypoglycaemia in fasted healthy subjects. Clin Sci (Lond) 95:719-724
32. Todd JF, Stanley SA, Roufosse CA, Bishop AE, Khoo B, Bloom SR, Meeran K 2003 A tumour that secretes glucagon-like peptide-1 and somatostatin in a patient with reactive hypoglycaemia and diabetes. Lancet 361:228-230
33. Lestradet H, Deschamps I, Giron B 1976 Insulin and free fatty acid levels during oral glucose tolerance tests and their relation to age in 70 healthy children. Diabetes 25:505-508
34. Josefsberg Z, Vilunski E, Hanukuglu A, Bialk O, Brown M, Karp M, Laron Z 1976 Glucose and insulin responses to an oral glucose load in normal children and adolescents in Israel. Isr J Med Sci 12:189-194
35. Meier JJ, Nauck MA, Kranz D, Holst JJ, Deacon CF, Gaeckler D, Schmidt WE, Gallwitz B 2004 Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects. Diabetes 53:654-662
36. Rivkees SA, Crawford JD 1987 Hypoglycemia pathogenesis in children with dumping syndrome. Pediatrics 80:937-942
37. Hirsig J, Baals H, Tuchschmid P, Spitz L, Stauffer UG 1984 Dumping syndrome following Nissen's fundoplication: a cause for refusal to feed. J Pediatr Surg 19:155-157
38. Borovoy J, Furuta L, Nurko S 1998 Benefit of uncooked cornstarch in the management of children with dumping syndrome fed exclusively by gastrostomy. Am J Gastroenterol 93:814-818
39. Lehnert H, Beyer J, Weber P, Krause U, Schrezenmeir J 1990 Treatment of severe reactive hypoglycemia with a somatostatin analogue (SMS 201-995). Arch Intern Med 150:2401-2402
40. Khoshoo V, Reifen RM, Gold BD, Sherman PM, Pencharz PB 1991 Nutritional manipulation in the management of dumping syndrome. Arch Dis Child 66:1447-1448